Invention Grant
- Patent Title: 3-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
-
Application No.: US15312450Application Date: 2015-05-18
-
Publication No.: US10245266B2Publication Date: 2019-04-02
- Inventor: Peter H. Schafer , Lei Wu , Ying Ye
- Applicant: CELGENE CORPORATION
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- International Application: PCT/US2015/031345 WO 20150518
- International Announcement: WO2015/179276 WO 20151126
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/5377 ; A61K31/5355 ; G01N33/68
Abstract:
Provided herein are methods of using compounds and compositions for treating, managing, and/or preventing systemic lupus erythematosus (SLE). Pharmaceutical compositions and dosing regimens for use in the methods are also provided herein.
Public/Granted literature
Information query
